CONCLuSiONS: This study provides the strongest evidence yet that H. pylori infection is strongly inversely associated with BE. This effect is probably mediated by a decrease in GERD in infected patients, since the protective effect disappears in patients with GERD symptoms.
IntroductIon
In the United States, 16,940 new cases of esophageal cancer and 15,690 deaths from esophageal cancer are expected to occur in 2017 [1] . While recent decades have witnessed a decline in the incidence of squamous cell carcinoma of the esophagus [2] , a rising trend of esophageal adenocarcinoma (EAC) incidence has been observed in many developed countries [3] . In the United States, the annual incidence of EAC has increased nine-fold since the early 1970s [4] .
Barrett's esophagus (BE), a condition in which the normal squamous mucosa of the esophagus is replaced by columnar , Hashem B. El-Serag, MD, MPH 8, 9 , Joel H. Rubenstein, MD, MSc 10, 11 and Aaron P. Thrift, PhD 1, 12 OBJECTiVES:
Epidemiological studies of Helicobacter pylori infection and risk of Barrett's esophagus (BE) have reported conflicting results. We examined the association between H. pylori infection and BE and sought to determine whether the association is mediated by gastroesophageal reflux disease (GERD) and to identify potential effect modifiers.
METHODS:
We used individual level data from 1308 patients with BE (cases), 1388 population-based controls, and 1775 GERD controls in the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). We estimated study-specific odds ratios (ORs) and 95% CIs using multivariable logistic regression models and obtained summary risk estimates using a random-effects meta-analytic approach. We examined potential effect modification by waist-to-hip ratio (WHR), body mass index (BMI), and smoking status by conducting stratified analyses.
RESuLTS:
For comparisons with population-based controls, H. pylori infection was inversely associated with the risk of BE (adjusted OR = 0.44, 95% CI = 0.36-0.55), with no evidence of between-study heterogeneity (I 2 = 0%). A stronger inverse association between H. pylori and BE was observed among individuals with the CagA-positive strain (P for interaction = 0.017). We found no evidence of interaction between WHR, BMI, smoking status, and H. pylori infection on the risk of BE. There was no association between H. pylori infection and BE for comparisons with GERD controls (OR = 0.96, 95% CI = 0.67-1.37; I 2 = 48%).
Helicobacter pylori Infection Is Associated...
© 2018 The American College of Gastroenterology
The American Journal of GastroenteroloGy intestinal epithelium, is the precursor lesion for EAC [5] . Patients with BE have 10-55-fold higher risk of EAC than the general population [6] . Since BE is usually asymptomatic and remains clinically undetected, population-based studies have estimated a prevalence of 1.3-1.6% among general population [7, 8] , while clinic-based studies have estimated a prevalence of 18.2% among patients undergoing endoscopy [9] . Assessment of risk factors for BE allows for better understanding of disease pathophysiology and identification of new opportunities for disease prevention. Population-based case-control studies initiated in the past two decades have thus far consistently identified frequent symptoms of gastroesophageal reflux disease (GERD) [10] , obesity [11] , and possibly smoking [12] as risk factors for BE. A potential protective factor for BE is infection with Helicobacter pylori. While H. pylori, especially the CagA-positive (cytotoxinassociated gene product A-positive) strain, is a known strong risk factor for non-cardia gastric cancer (potentially accounting for 90% of cases worldwide each year) [13] , the infection could decrease gastric acid production and subsequently reduce the likelihood of developing GERD, a major risk factor for BE [14] . However, its role in reflux-induced esophageal injury and the effect of H. pylori eradication on GERD and reflux esophagitis continues to be debated [15] . A meta-analysis of 49 observational studies examining the association between H. pylori infection and the risk of BE published through 2010 found an inverse association but with considerable between-study heterogeneity [16] potentially from choice of control group (e.g., population-based vs. clinical controls) and BE case definition (e.g., with and without intestinal metaplasia, or incident vs. prevalent cases). While population controls are sampled from underlying population where cases arose and are asymptomatic, clinical controls represent a symptomatic population undergoing endoscopy and are the ideal comparison group for assessing whether an association with BE is mediated by GERD. Furthermore, the small size of these individual studies has also limited the precision of resulting estimates of association and few studies had data on CagA positivity status. Most studies were unable to adequately control for confounding and it is unknown to what extent these associations vary by population using harmonized adjusted models. Finally, investigations of whether these associations differ with respect to known risk factors for BE (e.g., obesity and cigarette smoking) have been limited due to small numbers upon stratification.
To better understand this relationship, we assessed whether H. pylori infection is associated with the risk of BE by pooling, harmonizing, and analyzing individual-level participant data from six case-control studies. We also sought to determine whether or not the association of H. pylori infection with BE is mediated by GERD.
MEthods

Study population
We analyzed individual-level participant data from the following six case-control studies in the international Barrett's and Esophageal Adenocarcinoma Consortium (BEACON, http://beacon.tlvnet.net/) that had available data on H. pylori infection status: the Houston Barrett's Esophagus study (based at the Michael E. DeBakey VA Medical Center at Houston, TX; hereafter "Houston") [17] ; the Factors Influencing the Barrett's/ Adenocarcinoma Relationship study (based in Ireland; "FINBAR") [18] ; the Epidemiology and Incidence of Barrett's Esophagus study (based in the Kaiser Permanente Northern California population; "KPNC") [19] ; The Newly Diagnosed Barrett's Esophagus Study (based at the University of Michigan and Ann Arbor Veterans Affairs Medical Center at Ann Arbor, MI; "NDB") [9] ; the Study of Digestive Health (based in Brisbane, Australia; "SDH") [20] ; and the Epidemiologic Case-Control Study of Barrett's Esophagus (Chapel Hill, NC; "UNC"). The NDB study included only males (cases and controls) [9] and the UNC study only included BE cases and GERD controls. The Institutional Review Boards or Research Ethics Committees of each institution approved the acquisition and pooling of data for the present analysis. Participants provided written informed consent to take part in the studies.
In all studies, BE cases were persons with endoscopic evidence of columnar mucosa in the tubular esophagus and specialized intestinal metaplasia in an esophageal biopsy. We compared cases of BE with population-based controls, representing the underlying source population from which cases arose, and separately with GERD controls, representing the population undergoing endoscopy from which cases are diagnosed. GERD controls were participants who either were found to have erosive esophagitis on endoscopy or carried a clinician's diagnosis of GERD. Studyspecific definitions for cases and controls are detailed in Supplementary Table 1 . Owing to low numbers of cases from other ethnic groups, we restricted our analyses to non-Hispanic white study participants.
Study variables
The main exposure was H. pylori infection status (negative vs. positive), which was determined at each study center using assays blinded to case-control status running in mixed batches of cases and controls. The enzyme-linked immunosorbent assays applied in the individual studies has been validated in other ethnic groups [21] . Cases and controls from FINBAR, KPNC, and NDB studies were also tested for antibodies to the H. pylori CagA protein.
Potential confounding variables were available from all studies as part of a core dataset and were previously harmonized by the BEACON coordinating center [12, [22] [23] [24] [25] . Variables selected a priori as adjustment factors included age (<50, 50-<60, 60-<70, ≥70 years), sex (except for NDB, which included only males), highest level of education (school only, tech/diploma, university), cigarette smoking status (never, former, current), and body mass index (BMI; <25, 25-29.9, ≥30 kg/m 2 ). In a subset of studies, we also pooled and harmonized data on patient's waist and hip measurements. Among participants with relevant data, a sensitivity analysis was also conducted to replace BMI in the model with waist-to-hip ratio (WHR) in quartile categorization to adjust for the effect of abdominal obesity instead of overall obesity. 
Statistical analysis
Our primary analyses compared BE cases with population-based controls. We assessed the association between H. pylori infection and BE using a two-stage analytic approach [26] . In the first stage, we used unconditional logistic regression models to estimate study-specific odds ratios (ORs) and 95% confidence intervals (CIs). In the second stage, the study-specific ORs were pooled using random-effects meta-analytic models to generate a summary OR. We used the inconsistency index, I
2 , and corresponding p-value to assess heterogeneity between studies [27] . The I 2 statistic estimates the percentage of total variation across studies due to heterogeneity. An I 2 statistic of 0% indicates no heterogeneity that cannot be attributed to chance, whereas larger values indicate increasing heterogeneity beyond chance [27] . We explored possible heterogeneity of the effect of H. pylori infection on risk of BE through analyses stratified by cigarette smoking status, BMI, and WHR (<median vs. ≥median; median determined separately for each study). Potential interactions were assessed by fitting the interaction term between H. pylori infection status and the stratified variable into the model. Likelihood ratio tests of nested models with and without the interaction term were performed. To evaluate whether the virulent strain types of H. pylori could impact the effect of H. pylori on risk of BE, we further divided subjects into three groups: negative for H. pylori infection (reference group), positive for H. pylori infection with negative CagA antibody status; and positive for H. pylori infection with positive CagA antibody status. Finally, because the presence of H. pylori is thought to decrease gastric acid production and subsequently reduce the likelihood of developing GERD, we evaluated whether the association between H. pylori infection and BE was potentially mediated by GERD by comparing BE cases with GERD controls. To further verify an indirect pathway from H. pylori to BE through GERD, we also examined the association between H. pylori and GERD by comparing population-based controls with GERD controls. All analyses were conducted using SAS 9.4 (SAS Inc., Cary, NC, USA) and Cochrane review manager 5.3 (Cochrane, London, UK). Statistical significance was determined at α = 0.05, and all p-values for statistical significance were two sided.
rEsults
We included data from 1308 BE cases, 1388 population-based controls, and 1775 GERD controls. Across the six studies, 29.6% of population-based controls were H. pylori positive, while 17.2% of BE cases were H. pylori positive. However, the prevalence of H. pylori positive among controls (and cases) varied considerably across the six studies ( Table 1) . For example, prevalence of H. pylori positivity in population-based controls ranged from 18.9% in SDH to 62.1% in FINBAR; in GERD controls, from 4.4% in UNC to 42.4% in FINBAR; and in BE cases, from 5.2% in UNC to 43.3% in FINBAR.
In comparisons with population-based controls, we found an inverse association between H. pylori infection and BE. In the unadjusted analysis, infection with H. pylori was associated with 50% lower odds of BE (summary OR = 0.50, 95% CI = 0.41-0.61, I 2 = 0%, p = 0.88). In models adjusted for age, sex, education, (Fig. 1) . As evidenced by the I 2 statistics, no heterogeneity was observed across the included studies. Sensitivity analysis showed no alteration of associations after replacing BMI in the model with WHR (summary OR = 0.45, 95% CI = 0.36-0.56; I 2 = 0%, p = 0.52) (Supplementary Figure 1) . We examined the association between H. pylori and BE within strata of known risk factors for BE ( Table 2) . We found consistently that H. pylori infection was inversely associated with BE across strata of smoking status (p-interaction = 0.867) and WHR (p-interaction = 0.684). We found some evidence for a stronger inverse association with H. pylori infection among persons with normal BMI (summary OR = 0.27, 95% CI = 0.13-0.56) than among overweight (summary OR = 0.51, 95% CI = 0.36-0.71) or obese (summary OR = 0.47, 95% CI = 0.33-0.80) persons, though the interaction term for H. pylori and BMI was not statistically significant (p-interaction = 0.20).
Further analysis was conducted to examine whether the inverse association differed by CagA (+/−) virulent strains of H. pylori infection ( Table 3) . By using the meta-analytical approach based on three studies (FINBAR, KPNC, and NDB) with available CagA status information, the inverse association was somewhat stronger among subjects with CagA-positive strain (summary OR = 0.33, Test for overall effect: Z = 7.50 (P < 0.00001) Finally, we examined for mediation by GERD by comparing BE cases with GERD controls. In the adjusted model, we found no association between H. pylori infection and the odds of BE (summary OR = 0.96, 95% CI = 0.67-1.37, I 2 = 48%, p = 0.10) (Fig. 2) . The existence of an indirect pathway from H. pylori infection to BE through GERD was further corroborated by the finding that H. pylori infection was strongly inversely associated with odds of GERD for comparisons of GERD controls with populationbased control (summary OR = 0.52, 95% CI = 0.35-0.78, I 2 = 69%, p = 0.02) (Fig. 3) .
dIscussIon
In this large pooled analysis of individual-level participant data from six well-characterized case-control studies in BEACON, we found that H. pylori infection was associated with over 50% lower odds of BE. The magnitude of the inverse association was consistent across the included studies. In the stratified analyses, H. pylori infection was associated with lower odds of BE in all population subgroups. However, we found no association between H. pylori infection and BE for comparisons with GERD controls, consistent with the hypothesis that the association between H. pylori infection and BE is mediated by GERD. Moreover, infection with more virulent strains provides increased protection against BE. While H. pylori infection decreases the risk of GERD in infected individuals, once a patient has GERD, there is no protection from BE associated with H. pylori.
Our understanding of the relationship between H. pylori infection and BE has been hampered by conflicting results from studies often too small to adequately address the issue and of varying design. While some studies reported lower risk of BE associated with H. pylori infection (using population-based controls [19, 28] , endoscopy-negative controls [17, 29] , or GERD controls [30, 31] ), there was no association in other studies [32, 33] . The current analysis of individual-level participant data from studies participating in BEACON is much larger than any of these previous studies, and this larger sample size provided for greater statistical power and precision of risk estimates. Furthermore, the use of pooled and harmonized individual-level participant data provided more comparable statistical estimates than standard meta-analysis, which pool published ORs that differ in their variable definitions and the confounders included. In addition, the availability of both population-based controls and GERD controls allowed for comparisons with the underlying source population from which cases arose and the population undergoing endoscopy from which cases are diagnosed. Importantly, this also allowed us to examine whether H. pylori is associated with BE in the presence and/or absence of GERD; this is an important clinical question. Therefore, the results of this analysis are the strongest available data to date regarding the association between H. pylori and BE.
BE is the recognized precursor lesion of EAC, and if H. pylori infection was associated with the risk of BE, one can expect to observe an association between H. pylori infection and EAC as well. The results from population-based studies do provide strong evidence for an inverse association between H. pylori infection and EAC [18] . Given the concordance of these data, associations between H. pylori infection and BE, as well as H. pylori infection and EAC, are likely to be real. The current results also provide strong evidence that H. pylori infection is associated with the risk of BE rather than risk of neoplastic progression in BE patients. In particular, we showed that H. pylori infection was strongly inversely associated with the risk of GERD. For symptomatic patients, there was no association between H. pylori infection and the risk of BE. Thus the emphasis should be on managing GERD in these patients and not minimizing treatment efforts in H. pylori.
Our study has several notable strengths. First, the consortium approach enabled generation of the largest reported cohort of participants with BE to date, upon which risk factor analysis has been performed. With over 1300 cases of BE, we had greater power to detect associations, if present, and report more precise estimates of association with H. pylori infection than in any previous study. Furthermore, the large size of the pooled database enabled greater sample size and statistical power for stratified analyses and the assessment of potential interactions. Second, since BEACON applied standardized protocols in harmonizing data and deriving variables standardized across studies, using individual-level participant data allows for many benefits over meta-analysis of published estimates, including building consistent statistical models across studies and studying novel questions. Third, we found little evidence of between-study heterogeneity, and the wide distribution of H. pylori prevalence across studies suggests that our findings are generalizable to most settings. Fourth, the availability of both population-based controls and GERD controls allowed us to postulate where H. pylori infection might be active in the pathogenesis of BE. This is important because it is feasible that a significant proportion of the population-based control group might unknowingly have BE, although such misclassification would bias results toward the null.
Our study also has a number of limitations. First, observational studies are subject to bias. Although analyses of multiple variables provided little evidence of confounding, we cannot exclude incomplete control of confounding. Further, our results may be due to reverse causation whereby BE patients may have been previously treated for H. pylori infection in the more distant past, thereby decreasing their antibody titers. Second, the measurements of CagA status were only limited in three studies, decreasing the precision of these estimates, and ruling out the possibility of stratified analyses. Third, most of the six studies included a mix of patients with newly diagnosed and prevalent diagnoses of BE, which could have biased the results unpredictably. Fourth, the absence of information on the presence, distribution, or severity of gastritis or gastric atrophy meant that we could not examine this factor as a possible explanation. The Houston study previously found extent of gastritis as a possible explanation.
In summary, this pooled analysis found evidence for an inverse association between H. pylori infection and the odds of BE, particularly the CagA-positive strain. However, the association 
